Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma

Glioblastoma (GB) is the most common malignant brain tumor. Drug resistance frequently develops in these tumors during chemotherapy. Therefore, predicting drug response in these patients remains a major challenge in the clinic. Thus, to improve the clinical outcome, more effective and tolerable comb...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Growth Metastasis
Egile Nagusiak: Das, Arabinda, Cheng, Ron Ron, Hilbert, Megan L.T., Dixon-Moh, Yaenette N., Decandio, Michele, Vandergrift, William Alex, Banik, Naren L., Lindhorst, Scott M., Cachia, David, Varma, Abhay K., Patel, Sunil J., Giglio, Pierre
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Libertas Academica 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667559/
https://ncbi.nlm.nih.gov/pubmed/26648752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CGM.S32801
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak